Cargando…

Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer

BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Cheng, Wang, Miao, Hou, Hui-Min, Liu, Jian-Yong, Zhang, Zhi-Peng, Wang, Xuan, Zhang, Ya-Qun, Li, Chun-Mei, Zhang, Wei, Wang, Jian-Ye, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717504/
https://www.ncbi.nlm.nih.gov/pubmed/35071549
http://dx.doi.org/10.12998/wjcc.v9.i36.11183
_version_ 1784624546640297984
author Pang, Cheng
Wang, Miao
Hou, Hui-Min
Liu, Jian-Yong
Zhang, Zhi-Peng
Wang, Xuan
Zhang, Ya-Qun
Li, Chun-Mei
Zhang, Wei
Wang, Jian-Ye
Liu, Ming
author_facet Pang, Cheng
Wang, Miao
Hou, Hui-Min
Liu, Jian-Yong
Zhang, Zhi-Peng
Wang, Xuan
Zhang, Ya-Qun
Li, Chun-Mei
Zhang, Wei
Wang, Jian-Ye
Liu, Ming
author_sort Pang, Cheng
collection PubMed
description BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate the diagnostic efficiency of a template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy in detecting PCa. METHODS: Data from patients with an increasing prostate-specific antigen (PSA) level but less than 20 ng/mL and at least one lesion suspicious for PCa on MRI from December 2015 to June 2018 were retrospectively analyzed. All patients underwent cognitive fusion transperineal template-guided targeted biopsy followed by randomized biopsy outside the targeted area. A total of 127 patients with complete data were included in the final analysis. A multivariable logistic regression analysis was conducted, and a two-sided P < 0.05 was considered statistically significant. RESULTS: PCa was detected in 66 of 127 patients, and 56 cases presented clinically significant PCa. Cognitive fusion targeted biopsy alone detected 59/127 cases of PCa, specifically 52/59 cases with clinically significant PCa and 7/59 cases with clinically insignificant PCa. A randomized biopsy detected seven cases of PCa negative on targeted biopsy, and four cases had clinically significant PCa. PSA density (OR: 1.008, 95%CI: 1.003-1.012, P = 0.001; OR: 1.006, 95%CI: 1.002-1.010, P = 0.004) and Prostate Imaging-Reporting and Data System (PI-RADS) scores (both P < 0.001) were independently associated with the results of cognitive fusion targeted biopsy combined with randomized biopsy and targeted biopsy alone. CONCLUSION: This single-centered study proposed a feasible template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy. Patients with higher PSAD and PI-RADS scores were more likely to be diagnosed with PCa.
format Online
Article
Text
id pubmed-8717504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87175042022-01-20 Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer Pang, Cheng Wang, Miao Hou, Hui-Min Liu, Jian-Yong Zhang, Zhi-Peng Wang, Xuan Zhang, Ya-Qun Li, Chun-Mei Zhang, Wei Wang, Jian-Ye Liu, Ming World J Clin Cases Retrospective Study BACKGROUND: Prostate cancer (PCa) is one of the most common cancers among men. Various strategies for targeted biopsy based on multiparametric magnetic resonance imaging (mp-MRI) have emerged, which may improve the accuracy of detecting clinically significant PCa in recent years. AIM: To investigate the diagnostic efficiency of a template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy in detecting PCa. METHODS: Data from patients with an increasing prostate-specific antigen (PSA) level but less than 20 ng/mL and at least one lesion suspicious for PCa on MRI from December 2015 to June 2018 were retrospectively analyzed. All patients underwent cognitive fusion transperineal template-guided targeted biopsy followed by randomized biopsy outside the targeted area. A total of 127 patients with complete data were included in the final analysis. A multivariable logistic regression analysis was conducted, and a two-sided P < 0.05 was considered statistically significant. RESULTS: PCa was detected in 66 of 127 patients, and 56 cases presented clinically significant PCa. Cognitive fusion targeted biopsy alone detected 59/127 cases of PCa, specifically 52/59 cases with clinically significant PCa and 7/59 cases with clinically insignificant PCa. A randomized biopsy detected seven cases of PCa negative on targeted biopsy, and four cases had clinically significant PCa. PSA density (OR: 1.008, 95%CI: 1.003-1.012, P = 0.001; OR: 1.006, 95%CI: 1.002-1.010, P = 0.004) and Prostate Imaging-Reporting and Data System (PI-RADS) scores (both P < 0.001) were independently associated with the results of cognitive fusion targeted biopsy combined with randomized biopsy and targeted biopsy alone. CONCLUSION: This single-centered study proposed a feasible template for cognitive MRI-ultrasound fusion transperineal targeted plus randomized biopsy. Patients with higher PSAD and PI-RADS scores were more likely to be diagnosed with PCa. Baishideng Publishing Group Inc 2021-12-26 2021-12-26 /pmc/articles/PMC8717504/ /pubmed/35071549 http://dx.doi.org/10.12998/wjcc.v9.i36.11183 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Pang, Cheng
Wang, Miao
Hou, Hui-Min
Liu, Jian-Yong
Zhang, Zhi-Peng
Wang, Xuan
Zhang, Ya-Qun
Li, Chun-Mei
Zhang, Wei
Wang, Jian-Ye
Liu, Ming
Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title_full Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title_fullStr Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title_full_unstemmed Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title_short Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
title_sort cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717504/
https://www.ncbi.nlm.nih.gov/pubmed/35071549
http://dx.doi.org/10.12998/wjcc.v9.i36.11183
work_keys_str_mv AT pangcheng cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT wangmiao cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT houhuimin cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT liujianyong cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT zhangzhipeng cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT wangxuan cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT zhangyaqun cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT lichunmei cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT zhangwei cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT wangjianye cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer
AT liuming cognitivemagneticresonanceimagingultrasoundfusiontransperinealtargetedbiopsycombinedwithrandomizedbiopsyindetectionofprostatecancer